Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Wouter H Bos"'
Publikováno v:
Rheumatology International, 43(4), 677-685. Springer Verlag
Seppen, B F, Wiegel, J, Nurmohamed, M T, Bos, W H & ter Wee, M M 2023, ' Facilitators and barriers to adhere to monitoring disease activity with ePROs : a focus group study in patients with inflammatory arthritis ', Rheumatology International, vol. 43, no. 4, pp. 677-685 . https://doi.org/10.1007/s00296-022-05263-5
Seppen, B F, Wiegel, J, Nurmohamed, M T, Bos, W H & ter Wee, M M 2023, ' Facilitators and barriers to adhere to monitoring disease activity with ePROs : a focus group study in patients with inflammatory arthritis ', Rheumatology International, vol. 43, no. 4, pp. 677-685 . https://doi.org/10.1007/s00296-022-05263-5
Telemonitoring disease activity with electronic patient-reported outcomes (ePROs) may reduce the workload of rheumatic care by decreasing outpatient clinic visits. However, low adherence to reporting ePROs is frequently observed. Our objective was to
Publikováno v:
Rheumatology International. 43:651-657
Routine collection of electronic patient-reported outcomes (ePROs) can improve clinical care. However, a low response rate may counteract the benefits. To optimize adoption, the aim of this study was to investigate which patient factors and/or timing
Autor:
Bart Seppen, Jimmy Wiegel, Marieke M. ter Wee, Dirkjan van Schaardenburg, Leo D. Roorda, Michael T. Nurmohamed, Maarten Boers, Wouter H. Bos
Publikováno v:
Seppen, B, Wiegel, J, Ter Wee, M M, van Schaardenburg, D, Roorda, L D, Nurmohamed, M T, Boers, M & Bos, W H 2022, ' Smartphone-Assisted Patient-Initiated Care Versus Usual Care in Patients With Rheumatoid Arthritis and Low Disease Activity : A Randomized Controlled Trial ', Arthritis & rheumatology, vol. 74, no. 11, pp. 1737-1745 . https://doi.org/10.1002/art.42292
Arthritis and Rheumatology, 74(11), 1737-1745. John Wiley and Sons Ltd
Arthritis & rheumatology, 74(11), 1737-1745. John Wiley and Sons Ltd
Arthritis and Rheumatology, 74(11), 1737-1745. John Wiley and Sons Ltd
Arthritis & rheumatology, 74(11), 1737-1745. John Wiley and Sons Ltd
OBJECTIVE: We developed a smartphone application for patients with rheumatoid arthritis (RA) that allows them to self-monitor their disease activity in between clinic visits by answering a weekly Routine Assessment of Patient Index Data 3. This study
Autor:
Bart F Seppen, Marjolein J E Greuter, Jimmy Wiegel, Marieke M ter Wee, Maarten Boers, Michael T Nurmohamed, Wouter H Bos
Publikováno v:
Rheumatology.
ObjectivesSelf-monitoring and patient-initiated care (PIC) leads to fewer outpatient clinic visits in patients with established RA with low disease activity (LDA) while healthcare outcomes are similar. This study assesses the cost-effectiveness of PI
Autor:
Laura Boekel, Femke Hooijberg, Yaëlle R Besten, Erik H Vogelzang, Maurice Steenhuis, Maureen Leeuw, Sadaf Atiqi, Ronald van Vollenhoven, Willem F Lems, Wouter H Bos, Carla A Wijbrandts, Martijn Gerritsen, Charlotte Krieckaert, Alexandre E Voskuyl, Irene E van der Horst-Bruinsma, Sander W Tas, Maarten Boers, Theo Rispens, Michael T Nurmohamed, Gertjan Wolbink
Publikováno v:
Boekel, L, Hooijberg, F, Besten, Y R, Vogelzang, E H, Steenhuis, M, Leeuw, M, Atiqi, S, van Vollenhoven, R, Lems, W F, Bos, W H, Wijbrandts, C A, Gerritsen, M, Krieckaert, C, Voskuyl, A E, van der Horst-Bruinsma, I E, Tas, S W, Boers, M, Rispens, T, Nurmohamed, M T & Wolbink, G 2022, ' COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases ', The Lancet Rheumatology, vol. 4, no. 5, pp. e310-e313 . https://doi.org/10.1016/S2665-9913(22)00009-1
The Lancet Rheumatology, 4(5), e310-e313. Lancet Publishing Group
The Lancet. Rheumatology, 4, 5, pp. e310-e313
The Lancet. Rheumatology, 4, e310-e313
The Lancet Rheumatology, 4(5), e310-e313. Lancet Publishing Group
The Lancet. Rheumatology, 4, 5, pp. e310-e313
The Lancet. Rheumatology, 4, e310-e313
Contains fulltext : 251785.pdf (Publisher’s version ) (Closed access)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b6a98b6a8e0f34281f96a29a425b0ab
https://research.vumc.nl/en/publications/5be54c54-3607-4f2f-8d47-3794c52fdac9
https://research.vumc.nl/en/publications/5be54c54-3607-4f2f-8d47-3794c52fdac9
Autor:
Erik H Vogelzang, Femke Hooijberg, Sander W. Tas, Paul L. Klarenbeek, Gertjan Wolbink, Laura Boekel, Wouter H Bos
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-6 (2021)
Arthritis Research & Therapy
Arthritis Research & Therapy
Clinical research projects often use traditional methods in which data collection and signing informed consent forms rely on patients’ visits to the research institutes. However, during challenging times when the medical community is in dire need o
Autor:
Calin D. Popa, Dirkjan van Schaardenburg, Ed N. Griep, Mirian Starmans-Kool, D. Marsman, Laurette van Boheemen, Michael T. Nurmohamed, Wouter H Bos, Alper M. van Sijl, Marian H. van Beers-Tas, Samina A. Turk, Maarten Boers
Publikováno v:
RMD Open, 7(1):e001591. BMJ Publishing Group
RMD open, 7(1):e001591. BMJ Publishing Group
RMD Open, Vol 7, Iss 1 (2021)
RMD Open
van Boheemen, L, Turk, S, Beers-Tas, M V, Bos, W, Marsman, D, Griep, E N, Starmans-Kool, M, Popa, C D, van Sijl, A, Boers, M, Nurmohamed, M T & van Schaardenburg, D 2021, ' Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: Results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial ', RMD Open, vol. 7, no. 1, e001591 . https://doi.org/10.1136/rmdopen-2021-001591
RMD open, 7(1):e001591. BMJ Publishing Group
RMD Open, Vol 7, Iss 1 (2021)
RMD Open
van Boheemen, L, Turk, S, Beers-Tas, M V, Bos, W, Marsman, D, Griep, E N, Starmans-Kool, M, Popa, C D, van Sijl, A, Boers, M, Nurmohamed, M T & van Schaardenburg, D 2021, ' Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: Results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial ', RMD Open, vol. 7, no. 1, e001591 . https://doi.org/10.1136/rmdopen-2021-001591
ObjectivesPersons at high risk of rheumatoid arthritis (RA) might benefit from a low-risk pharmacological intervention aimed at primary prevention. Previous studies demonstrated disease-modifying effects of statins in patients with RA as well as an a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a52ebb5bb7e0e3ad5eef3550b93c042
https://research.vumc.nl/en/publications/216fdbf1-4b47-49aa-9b2f-da296778c04b
https://research.vumc.nl/en/publications/216fdbf1-4b47-49aa-9b2f-da296778c04b
Publikováno v:
Rheumatology International
Rheumatology International, 41(3), 565-573. Springer
Rheumatology international, 41(3), 565-573. Springer
Rheumatology International, 41(3), 565-573. Springer
Rheumatology international, 41(3), 565-573. Springer
To describe the delivery of care for patients with rheumatic and musculoskeletal diseases (RMDs) from the perspective of rheumatologists in the Netherlands during the first months of the COVID-19 pandemic. A mixed methods design was used with quantit
Autor:
Wouter H Bos, Bart F. Seppen, Fabio S Catarinella, Merel J l'Ami, Franktien Turkstra, Jimmy Wiegel, Maarten Boers, Sharon Duarte dos Santos Rico
Publikováno v:
Seppen, B F, Wiegel, J, l'ami, M J, dos Santos Rico, S D, Catarinella, F S, Turkstra, F, Boers, M & Bos, W H 2020, ' Feasibility of Self-Monitoring Rheumatoid Arthritis With a Smartphone App : Results of Two Mixed-Methods Pilot Studies ', JMIR formative research, vol. 4, no. 9, e20165, pp. e20165 . https://doi.org/10.2196/20165, https://doi.org/10.2196/20165
JMIR Formative Research, Vol 4, Iss 9, p e20165 (2020)
JMIR formative research, 4(9):e20165. JMIR Publications Inc.
JMIR Formative Research
JMIR Formative Research, Vol 4, Iss 9, p e20165 (2020)
JMIR formative research, 4(9):e20165. JMIR Publications Inc.
JMIR Formative Research
Background Several mobile apps that monitor symptoms of rheumatoid arthritis (RA) exist, but a recent systematic review indicated that high-quality apps are lacking. When patients self-monitor their own disease with patient-reported outcomes (PROs) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1516923046aa4698b8c48373d76b8fb0
https://research.vumc.nl/en/publications/ad1f892d-f930-4d73-aaf4-7353b452fb61
https://research.vumc.nl/en/publications/ad1f892d-f930-4d73-aaf4-7353b452fb61
Autor:
Bart F Seppen, Jimmy Wiegel, Merel J L'ami, Sharon Duarte dos Santos Rico, Fabio S Catarinella, Franktien Turkstra, Maarten Boers, Wouter H Bos
BACKGROUND Several mobile apps that monitor symptoms of rheumatoid arthritis (RA) exist, but a recent systematic review indicated that high-quality apps are lacking. When patients self-monitor their own disease with patient-reported outcomes (PROs) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d39b0d647e6e97517737d2271e1d9e20
https://doi.org/10.2196/preprints.20165
https://doi.org/10.2196/preprints.20165